AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2663159 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclopirox olamine lotion 1%
Number of subjects: 89
Study 2663159 — intervention group
Group type: COMPARATOR
Intervention: Vehicle alone
Number of subjects: 89
Study 31216215 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac (10-mg tablets every 8 h)
Number of subjects: 37
Study 31216215 — intervention group
Group type: COMPARATOR
Intervention: Gabapentin (300-mg capsules every 8 h)
Number of subjects: 37
Study 30016518 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention regions (Healthy Together Victoria)
Number of subjects: 107
Study 30016518 — intervention group
Group type: COMPARATOR
Intervention: Comparison regions (non-intervention)
Number of subjects: 107
Study 26946615 — intervention group
Group type: EXPERIMENTAL
Intervention: Bloodletting therapy at local myofascial trigger points and acupuncture at Jiaji (EX-B 2) points
Number of subjects: 66
Study 26946615 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine block therapy
Number of subjects: 66
Study 22462436 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS-RUTF
Number of subjects: 45
Study 22462436 — intervention group
Group type: COMPARATOR
Intervention: P-RUTF
Number of subjects: 45
Study 23167854 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical Resuscitation Device (MRD)
Number of subjects: 80
Study 23167854 — intervention group
Group type: COMPARATOR
Intervention: Standard Basic Life Support (BLS)
Number of subjects: 80
Study 21123501 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflective blogging
Number of subjects: 58
Study 17645494 — intervention group
Group type: EXPERIMENTAL
Intervention: Nei-Guan point acupressure
Number of subjects: 66
Study 17645494 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 17645494 — intervention group
Group type: COMPARATOR
Intervention: Control (conventional intravenous treatment)
Number of subjects: 66
Study 15702859 — intervention group
Group type: EXPERIMENTAL
Intervention: L. plantarum 299v in an oatmeal-fermented drink (10(9) CFU/ml) given twice daily
Number of subjects: 32
Study 15702859 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 11790498 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc‐labelled lactose inhaled at four inspiratory flows (30, 40, 60, and 80 l/min)
Number of subjects: 8
Study 10344293 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term hypoxia (100% N2)
Number of subjects: 8
Study 10344293 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term hypoxia (100% N2) combined with hypercapnia (95% N2-5% CO2)
Number of subjects: 8
Study 10344293 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term hypercapnia (95% N2-5% CO2)
Number of subjects: 8
Study 10344293 — intervention group
Group type: COMPARATOR
Intervention: Air (control group)
Number of subjects: 8
Study 7573260 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine (5 mg twice a day, slow-release capsules)
Number of subjects: 54
Study 7573260 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 7573260 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 54
Study 2406228 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Radiation Group (PRG): further irradiation to a total dose of 90 Gy by the cone‐down and assault technique.
Number of subjects: 78
Study 2406228 — intervention group
Group type: COMPARATOR
Intervention: Positive Observation Group (POG): no further irradiation, followed periodically.
Number of subjects: 78
Study 2406228 — intervention group
Group type: COMPARATOR
Intervention: Negative Observation Group (NOG): pathology negative patients followed periodically.
Number of subjects: 78
Study 6768079 — intervention group
Group type: EXPERIMENTAL
Intervention: Apomorphine (continuous IV infusion for 180-240 min)
Number of subjects: 0
Study 6768079 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-infusion period (240 min after apomorphine infusion)
Number of subjects: 0
Study 6768079 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol or sulpiride (dopamine receptor blocking agents)
Number of subjects: 0
Study 6626789 — intervention group
Group type: EXPERIMENTAL
Intervention: Elated mood
Number of subjects: 0
Study 6626789 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed mood
Number of subjects: 0
Study 6626789 — intervention group
Group type: COMPARATOR
Intervention: Neutral mood
Number of subjects: 0
Study 30755129 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer specialist services
Number of subjects: 71
Study 29371007 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5 mg
Number of subjects: 178
Study 29371007 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 178
Study 26275929 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleaching enzyme-based toothpaste (White Kin(®))
Number of subjects: 48
Study 26275929 — intervention group
Group type: COMPARATOR
Intervention: Placebo toothpaste
Number of subjects: 48
Study 24787908 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol (800,000 IU, 4000 IU daily)
Number of subjects: 23
Study 24787908 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 21434968 — intervention group
Group type: EXPERIMENTAL
Intervention: Ideal body image (IBI)
Number of subjects: 402
Study 19857313 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics for mild diverticulitis
Number of subjects: 14000
Study 19857313 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective surgical resection for recurrent diverticulitis
Number of subjects: 14000
Study 19857313 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic peritoneal lavage for purulent peritonitis
Number of subjects: 14000
Study 19857313 — intervention group
Group type: EXPERIMENTAL
Intervention: Resection with primary anastomosis for Hinchey III or IV diverticulitis
Number of subjects: 14000
Study 17481486 — intervention group
Group type: EXPERIMENTAL
Intervention: TIPS
Number of subjects: 930
Study 17481486 — intervention group
Group type: COMPARATOR
Intervention: Surgical shunts
Number of subjects: 930
Study 16351775 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous fumarate syrup (20 mg elemental Fe twice daily)
Number of subjects: 169
Study 16351775 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 169
Study 12438475 — intervention group
Group type: EXPERIMENTAL
Intervention: Two weeks of prednisolone 20 mg daily followed by two weeks of prednisolone 10 mg daily (n = 53)
Number of subjects: 109
Study 12438475 — intervention group
Group type: COMPARATOR
Intervention: Two weeks of prednisolone 20 mg daily and two weeks of placebo (n = 56)
Number of subjects: 109
Study 12438475 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 109
Study 12438475 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow up electrodiagnosis
Number of subjects: 109
Study 10349956 — intervention group
Group type: EXPERIMENTAL
Intervention: Mupirocin
Number of subjects: 141
Study 10349956 — intervention group
Group type: COMPARATOR
Intervention: Bacitracin
Number of subjects: 141
Study 9389675 — intervention group
Group type: EXPERIMENTAL
Intervention: Urodilatin infusion (40 ng / kg bw / min for 6 days)
Number of subjects: 24
Study 9389675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 2025672 — intervention group
Group type: EXPERIMENTAL
Intervention: Invitations to attend screening (n = 163)
Number of subjects: 243
Study 2025672 — intervention group
Group type: COMPARATOR
Intervention: No invitations (Control group, n = 80)
Number of subjects: 243
Study 7262217 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand trajectory and joint angular curves observed during pointing movements.
Number of subjects: 0
Study 31794968 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompt Mental Health Care (PMHC)
Number of subjects: 681
Study 31794968 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 681
Study 31338716 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-delivered Seeking Safety (SS)
Number of subjects: 291
Study 31338716 — intervention group
Group type: COMPARATOR
Intervention: Clinician-delivered Seeking Safety (SS)
Number of subjects: 291
Study 28170279 — intervention group
Group type: EXPERIMENTAL
Intervention: 74 g raisins
Number of subjects: 10
Study 28170279 — intervention group
Group type: COMPARATOR
Intervention: 50 g glucose
Number of subjects: 10
Study 25579717 — intervention group
Group type: EXPERIMENTAL
Intervention: Salacia oblonga in non-diabetic CKD
Number of subjects: 60
Study 25579717 — intervention group
Group type: EXPERIMENTAL
Intervention: Salacia oblonga in diabetic CKD
Number of subjects: 60
Study 24016832 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive Statistical Iterative Reconstruction (ASIR) at 275 mAs
Number of subjects: 66
Study 24016832 — intervention group
Group type: COMPARATOR
Intervention: Filtered-Back-Projection (FBP) at 340 mAs
Number of subjects: 66
Study 24016832 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtered-Back-Projection (FBP) at 275 mAs
Number of subjects: 66
Study 24016832 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive Statistical Iterative Reconstruction (ASIR) at 340 mAs
Number of subjects: 66
Study 22287379 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care computed tomography (POC-CT) at the initial visit followed by medical therapy based on CT results (pre-CT group)
Number of subjects: 40
Study 22287379 — intervention group
Group type: COMPARATOR
Intervention: Empiric medical therapy (EMT) followed by POC posttreatment CT if symptoms persisted (EMT group)
Number of subjects: 40
Study 22287379 — intervention group
Group type: COMPARATOR
Intervention: Empiric medical therapy (EMT)
Number of subjects: 40
Study 22287379 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care computed tomography (POC-CT)
Number of subjects: 40
Study 22287379 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall prescriptions costs
Number of subjects: 40
Study 22287379 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall number of otolaryngology visits
Number of subjects: 40
Study 19560388 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring (CGM) using GlucoDay system for 48 hours
Number of subjects: 48
Study 19560388 — intervention group
Group type: COMPARATOR
Intervention: Usual self-monitoring of blood glucose (SMBG)
Number of subjects: 48
Study 19560388 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring (CGM) in T2D patients
Number of subjects: 48
Study 19560388 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring (CGM) in T1D patients
Number of subjects: 48
Study 17880502 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of 5% ALA solution
Number of subjects: 60
Study 17880502 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of 10% ALA solution
Number of subjects: 60
Study 17880502 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of 0.5%, 1%, 3%, 5%, or 10% ALA solution
Number of subjects: 60
Study 17880502 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of ALA solution
Number of subjects: 60
Study 17880502 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA typing analysis
Number of subjects: 60
Study 15326078 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-mm-tip catheter for short CTI (≤35 mm)
Number of subjects: 185
Study 15326078 — intervention group
Group type: COMPARATOR
Intervention: Cooled-tip catheter for long CTI (>35 mm)
Number of subjects: 185
Study 15326078 — intervention group
Group type: COMPARATOR
Intervention: 8-mm-tip catheter for long CTI (>35 mm)
Number of subjects: 185
Study 15326078 — intervention group
Group type: COMPARATOR
Intervention: Comparison of 8-mm-tip and cooled-tip catheters for long CTI (>35 mm)
Number of subjects: 185
Study 15326078 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with short and straight CTIs
Number of subjects: 185
Study 15326078 — intervention group
Group type: EXPERIMENTAL
Intervention: Pouch-like recesses and concave characteristics
Number of subjects: 185
Study 12821038 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) treatment
Number of subjects: 367
Study 12821038 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 367
Study 9933475 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplementation (500 mg/day of elemental calcium and 700 IU/day of cholecalciferol)
Number of subjects: 402
Study 7480474 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic method of transmission, little suffering
Number of subjects: 222
Study 7480474 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic method of transmission, much suffering
Number of subjects: 222
Study 7480474 — intervention group
Group type: EXPERIMENTAL
Intervention: Contagious method of transmission, little suffering
Number of subjects: 222
Study 7480474 — intervention group
Group type: EXPERIMENTAL
Intervention: Contagious method of transmission, much suffering
Number of subjects: 222
Study 7480474 — intervention group
Group type: EXPERIMENTAL
Intervention: Infectious method of transmission, little suffering
Number of subjects: 222
Study 7480474 — intervention group
Group type: EXPERIMENTAL
Intervention: Infectious method of transmission, much suffering
Number of subjects: 222
Study 7480474 — intervention group
Group type: EXPERIMENTAL
Intervention: Population likely to become ill: primarily marginal persons
Number of subjects: 222
Study 7480474 — intervention group
Group type: EXPERIMENTAL
Intervention: Population likely to become ill: anyone
Number of subjects: 222
Study 2196962 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg doxycycline
Number of subjects: 261
Study 2196962 — intervention group
Group type: COMPARATOR
Intervention: 300 mg doxycycline
Number of subjects: 261
Study 2196962 — intervention group
Group type: COMPARATOR
Intervention: Standard tetracycline
Number of subjects: 261
Study 7356102 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with 5‐fluorouracil, vinblastine, and cyclophosphamide
Number of subjects: 53
Study 7356102 — intervention group
Group type: COMPARATOR
Intervention: Control group (no chemotherapy)
Number of subjects: 53
Study 31738468 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise (20 min exercise 20% above lactate threshold)
Number of subjects: 33
Study 31738468 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity exercise (20 min exercise 20% below lactate threshold)
Number of subjects: 33
Study 31738468 — intervention group
Group type: COMPARATOR
Intervention: Control (seated rest)
Number of subjects: 33
Study 29884572 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol lock therapy (70% ethanol)
Number of subjects: 94
Study 29884572 — intervention group
Group type: COMPARATOR
Intervention: Placebo (heparinised saline)
Number of subjects: 94
Study 26449551 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) treatment
Number of subjects: 32
Study 24000106 — intervention group
Group type: EXPERIMENTAL
Intervention: Weaning from a convective incubator at 1,500 g body weight
Number of subjects: 21
Study 24000106 — intervention group
Group type: COMPARATOR
Intervention: Weaning from a convective incubator at 1,600 g body weight (control)
Number of subjects: 21
Study 24000106 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (1,500 g and 1,600 g)
Number of subjects: 21
Study 22414624 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Glycemic Index (LGI) diet (GI=47)
Number of subjects: 50
Study 22414624 — intervention group
Group type: COMPARATOR
Intervention: High Glycemic Index (HGI) diet (GI=90)
Number of subjects: 50
Study 22414624 — intervention group
Group type: EXPERIMENTAL
Intervention: Both LGI and HGI diets
Number of subjects: 50
Study 20506226 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous autologous ex vivo cultured MSCs (MSC group)
Number of subjects: 52
Study 20506226 — intervention group
Group type: COMPARATOR
Intervention: Control group (no MSC treatment)
Number of subjects: 52
Study 18302840 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based educational program for asthma patients
Number of subjects: 50
Study 15820237 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion XL (up to 450 mg/day)
Number of subjects: 162
Study 15820237 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study 12094199 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 0
Study 12094199 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study 12094199 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-PTCA CTFC
Number of subjects: 0
Study 12094199 — intervention group
Group type: EXPERIMENTAL
Intervention: CTFC/MLD ratio
Number of subjects: 0
Study 10969091 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (leaflet and counseling to limit pacifier use)
Number of subjects: 484
Study 10969091 — intervention group
Group type: COMPARATOR
Intervention: No continuous pacifier use
Number of subjects: 484
Study 8707164 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin
Number of subjects: 0
Study 8707164 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparins
Number of subjects: 0
Study 1855746 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronidase (150 units)
Number of subjects: 20
Study 1855746 — intervention group
Group type: COMPARATOR
Intervention: No hyaluronidase
Number of subjects: 20
Study 6133303 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco smoking
Number of subjects: 33
Study 6133303 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockade
Number of subjects: 33
Study 31152332 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-CdtB testing after epitope stabilization
Number of subjects: 131
Study 31152332 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-vinculin testing after epitope stabilization
Number of subjects: 131
Study 29724865 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous bolus administration of 400 µg TRH
Number of subjects: 16
Study 29724865 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 mL saline)
Number of subjects: 16
Study 27187893 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline (active pill plus placebo patch)
Number of subjects: 1246
Study 27187893 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch (active patch plus placebo pill)
Number of subjects: 1246
Study 27187893 — intervention group
Group type: COMPARATOR
Intervention: Placebo (placebo pill plus placebo patch)
Number of subjects: 1246
Study 24756119 — intervention group
Group type: EXPERIMENTAL
Intervention: Multipurpose solution
Number of subjects: 218
Study 24756119 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide care system
Number of subjects: 218
Study 24756119 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group not specified)
Number of subjects: 218
Study 22389136 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrahepatic IVC clamping
Number of subjects: 192
Study 22389136 — intervention group
Group type: COMPARATOR
Intervention: Low central venous pressure (CVP)
Number of subjects: 192
Study 20634735 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold air running
Number of subjects: 12
Study 20634735 — intervention group
Group type: COMPARATOR
Intervention: Warm air running
Number of subjects: 12
Study 17828765 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-week intervention group instructed in cultivating sacred moments
Number of subjects: 73
Study 17828765 — intervention group
Group type: COMPARATOR
Intervention: 3-week control group instructed in writing about daily activities
Number of subjects: 73
Study 15668602 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified skimmed milk containing 1,200 mg of calcium and 5.7 microg of vitamin D (group A)
Number of subjects: 80
Study 15668602 — intervention group
Group type: COMPARATOR
Intervention: Fortified skimmed milk containing 900 mg of calcium and 5.7 microg of vitamin D (group B)
Number of subjects: 80
Study 11881794 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin alfa 150 IU/kg or 300 IU/kg, administered 3 times weekly for 28 weeks
Number of subjects: 37
Study 11881794 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated patients)
Number of subjects: 37
Study 9893315 — intervention group
Group type: EXPERIMENTAL
Intervention: qigong instruction by a qigong master
Number of subjects: 26
Study 9893315 — intervention group
Group type: COMPARATOR
Intervention: sham master instruction
Number of subjects: 26
Study 7731768 — intervention group
Group type: EXPERIMENTAL
Intervention: iohexol 140 mgI/ml
Number of subjects: 89
Study 7731768 — intervention group
Group type: EXPERIMENTAL
Intervention: iohexol 240 mgI/ml
Number of subjects: 89
Study 7731768 — intervention group
Group type: EXPERIMENTAL
Intervention: iohexol 300 mgI/ml
Number of subjects: 89
Study 8460273 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle drainage
Number of subjects: 100
Study 8460273 — intervention group
Group type: COMPARATOR
Intervention: Conventional two-stage drainage
Number of subjects: 100
Study 8460273 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 100
Study 3954920 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 76
Study 3954920 — intervention group
Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 76
Study 31757838 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly exenatide (EQW)
Number of subjects: 13844
Study 31757838 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13844
Study 30304127 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanofilled self-adhesive light-cured protective coating (NPC)
Number of subjects: 32
Study 30304127 — intervention group
Group type: COMPARATOR
Intervention: Petroleum jelly
Number of subjects: 32
Study 26905020 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic radio frequency ablation assisted tumor enucleation
Number of subjects: 89
Study 26905020 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic partial nephrectomy
Number of subjects: 89
Study 25919902 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravascular ultrasound (IVUS) at baseline and follow-up
Number of subjects: 389
Study 23743576 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted training with no selective-attention demand
Number of subjects: 0